PUBLISHER: The Business Research Company | PRODUCT CODE: 1751078
PUBLISHER: The Business Research Company | PRODUCT CODE: 1751078
Postpartum depression (PPD) treatment refers to the medical and psychological care provided to individuals experiencing depression after childbirth. It typically involves a combination of therapy, medication, and support strategies aimed at alleviating symptoms such as persistent sadness, anxiety, fatigue, and difficulty bonding with the baby. Treatment options include medications, psychotherapy, hormonal therapy, and lifestyle interventions designed to improve maternal mental health and overall well-being.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main types of postpartum depression treatment include postpartum anxiety, postpartum blues, postpartum post-traumatic stress disorder (PTSD), postpartum obsessive-compulsive disorder (OCD), postpartum panic disorder, and postpartum psychosis. Postpartum anxiety is a condition in which new mothers experience excessive worry, fear, or nervousness after childbirth. Treatment options such as antidepressants, hormone therapy, psychotherapy, and other interventions are available for various demographics, including adolescents and adults. These treatments are distributed through various sales channels, including hospital pharmacies, retail pharmacies, and online pharmacies.
The postpartum depression treatment market research report is one of a series of new reports from The Business Research Company that provides postpartum depression treatment market statistics, including postpartum depression treatment industry global market size, regional shares, competitors with a postpartum depression treatment market share, detailed postpartum depression treatment market segments, market trends and opportunities, and any further data you may need to thrive in the postpartum depression treatment industry. This postpartum depression treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The postpartum depression treatment market size has grown strongly in recent years. It will grow from $1.19 billion in 2024 to $1.28 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historic period can be attributed to increasing awareness of maternal mental health, the growing prevalence of postpartum depression, advancements in antidepressant medications, rising acceptance of psychotherapy, and government initiatives supporting maternal mental health.
The postpartum depression treatment market size is expected to see strong growth in the next few years. It will grow to $1.70 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth during the forecast period can be attributed to the development of novel fast-acting treatments, the increasing adoption of digital mental health solutions, expanding insurance coverage for mental health services, rising demand for personalized treatment approaches, and a growing focus on hormonal therapies. Key trends expected in the forecast period include the emergence of neurosteroid-based therapies, the increasing use of telemedicine for postpartum care, the integration of AI in mental health diagnostics, the growing role of nutraceuticals and dietary interventions, and the expansion of employer-sponsored mental health programs.
The growing awareness of mental health issues during pregnancy is expected to drive the growth of the postpartum depression treatment market. Mental health issues during pregnancy encompass a range of emotional, psychological, and psychiatric conditions that affect women while they are pregnant. These issues are often heightened due to stress and hormonal changes, which can increase emotional vulnerability and make it more challenging for women to manage the physical, social, and psychological demands of pregnancy. Postpartum depression treatment helps alleviate symptoms such as sadness, anxiety, and fatigue, enhancing emotional resilience and fostering healthier mother-child bonding. For example, in October 2024, the Maternal Mental Health Leadership Alliance (MMHLA), a US-based nonprofit dedicated to improving maternal mental health, reported that maternal mental health conditions are the most common pregnancy complication, affecting 800,000 U.S. families annually. Alarmingly, 75% of these cases go untreated, posing long-term risks to mothers, babies, and families. This growing awareness is a major driver of the postpartum depression treatment market.
Companies in the postpartum depression treatment market are making significant advancements in diagnosis and treatment, particularly through the integration of multiple therapeutic modalities, such as prescription digital postpartum depression treatments. Prescription digital therapeutics (DTx) are clinically validated, mobile-based treatments that healthcare providers prescribe to manage and treat postpartum depression (PPD). For example, in April 2024, Curio Digital Therapeutics Inc., a US-based digital health company, announced FDA clearance for MamaLift Plus, the first prescription digital therapeutic for postpartum depression. This eight-week program delivers cognitive behavioral therapy (CBT), behavioral activation therapy (BAT), interpersonal therapy (IPT), and dialectical behavior therapy (DBT) via mobile devices under healthcare provider supervision. A pivotal study showed significantly higher rates of clinically meaningful improvement in Edinburgh Postnatal Depression Scale (EPDS) scores for MamaLift Plus users compared to a control group. This FDA clearance offers women a non-pharmaceutical option for treating mild to moderate PPD, making it more accessible.
In December 2022, Biogen Inc., a US-based company focusing on neurology therapies, partnered with Sage Therapeutics Inc. to develop treatments for major depressive disorder (MDD) and postpartum depression (PPD). This collaboration allows the companies to work together on medications for PPD, MDD, various mental health conditions, and neurological disorders such as essential tremors. Sage Therapeutics is a US-based company specializing in treatments for neurological conditions, including postpartum depression.
Major players in the postpartum depression treatment market are Biogen Inc., Inspira Health Network, LifeStance Health Inc., Max Healthcare Institute Limited, American Well Corporation, Sakra Premium Hospital Private Limited, Talkspace Inc., Mental Health America, 7 Cups Inc., Marinus Pharmaceuticals Inc., Brii Biosciences Limited, Beyond Blue Ltd, Blooming Wellness Center, Sage Therapeutics Inc., NURX Inc., Curio Digital Therapeutics Inc., Genesis Lifestyle Medicine, Postpartum Society of Florida, TalktoAngel, The Motherhood Center.
North America was the largest region in the postpartum depression treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in postpartum depression treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the postpartum depression treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The postpartum depression treatment market consists of revenues earned by entities by providing services such as psychotherapy, medication management, counseling, digital mental health solutions, and alternative therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The postpartum depression treatment market also includes sales of antidepressant medications, hormone-based therapies, digital health platforms, telehealth services, wearable devices, and mobile applications that support mental health management. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Postpartum Depression Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on postpartum depression treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for postpartum depression treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The postpartum depression treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.